AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

ENANTA PHARMACEUTICALS INC

Filed

February 15, 2023

Period of Report

February 13, 2023

Accession Number

0001062993-23-003712